Publications

Authors:

Gamba, Simona; Pertile, Paolo; Vogler, Sabine

Title:

The impact of managed entry agreements on pharmaceutical prices

Year:

2020

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Format:

Elettronico

Referee:

Sì

Name of journal:

Health Economics

ISSN of journal:

1057-9230

Page numbers:

1-16

Keyword:

managed entry agreements; pharmaceutical prices; risk-sharing agreements

Short description of contents:

Managed entry agreements (MEAs) have been used for several years, with the aim of curbing the growth of pharmaceutical expenditure and enhancing patient access to innovation. Yet, much remains to be understood about their economic implications. This paper studies the impact of MEAs on list prices, that is, prices before the deduction of any discount. Using a theoretical model, we show that, under most price setting regimes, the introduction of an MEA leads to a higher list price. This is confirmed by our empirical analysis of a sample of 156 medicines in six countries, providing a conservative estimate of the increase in price due to the MEA of 5.9%. A relevant policy implication is that payers may overestimate the financial gains that can be achieved through this  tool.

Product ID:

115452

Handle IRIS:

11562/1021580

Last Modified:

November 18, 2022

Bibliographic citation:

Gamba, Simona; Pertile, Paolo; Vogler, Sabine, The impact of managed entry agreements on pharmaceutical prices «Health Economics» , 2020 , pp. 1-16

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo